Intended for homologous use in the treatment acute and chronic wounds, EpiFix allografts may be stored at ambient conditions for up to 5 years and are available in a variety of sizes. Explore the use of EpiFix® in your wound treatment applications.
Mental health professionals are preparing to help health-care workers deal with the potential long-term effects of stress related to the COVID-19 pandemic.
Editor's note: APMA has help for members suffering from physician burnout at www.apma.org/wellbeing.
At a time of expanded use of telehealth services and new federal guidances, it’s important for physicians to remain current on what’s allowed and not allowed under HIPAA.
The DERMACLOSE Continuous External Tissue Expander device facilitates rapid tissue movement to reduce or reapproximate wounds. After the initial application has been completed the DERMACLOSE device does not require any additional tightening. Once the desired tissue expansion has occurred the device(s) can be removed and the wound can be closed with suture or staples.
Plantar fasciitis is one of the foot conditions that can result from too much barefoot walking.
Editor's note: April was Health Awareness Month and APMA has public education campaign materials that focus on the expertise of Today’s Podiatrist in diagnosing and treating plantar fasciitis and other conditions that may cause heel pain. The suite of member materials includes a tip-sheet, a special edition of Footprints, a free poster for your office, and more. Visit now!
Paying attention to such things as numbness and color changes in the feet can help identify problems early.
Editor's note: APMA's past Foot Health Awareness campaign materials are still available for you to share with your patients. Check out "Don't Lose Your Nerve to Diabetes."
Proprietary design addresses the insole issue: Rigid insoles do not allow the arch to move downward enough to fully handle the shock of a foot strike. Soft insoles collapse under pressure and cannot prevent the arch from flattening. Custom orthotics are designed to fit the patient’s flawed foot rather than make the foot healthy.
Several health-care groups have voiced their objections to elements in the Inpatient Prospective Payment System proposed rule related to price transparency.
